Use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products
The 'Draft guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products' has been released for public consultation as of 30 January 2014 with a deadline for comments of 30 July 2014.